AAAAAA

   
Results: 1-22 |
Results: 22
PHASE-II STUDY OF DEXVERAPAMIL PLUS ANTHRACYCLINE IN PATIENTS WITH METASTATIC BREAST-CANCER WHO HAVE PROGRESSED ON THE SAME ANTHRACYCLINE REGIMEN
Authors: WARNER E HEDLEY D ANDRULIS I MYERS R TRUDEAU M WARR D PRITCHARD KI BLACKSTEIN M GOSS PE FRANSSEN E ROCHE K KNIGHT S WEBSTER S FRASER RA OLDFIELD S HILL W KATES R
Citation: E. Warner et al., PHASE-II STUDY OF DEXVERAPAMIL PLUS ANTHRACYCLINE IN PATIENTS WITH METASTATIC BREAST-CANCER WHO HAVE PROGRESSED ON THE SAME ANTHRACYCLINE REGIMEN, Clinical cancer research, 4(6), 1998, pp. 1451-1457
CONSENSUS PROPOSAL FOR 5HT(3) ANTAGONISTS IN THE PREVENTION OF ACUTE EMESIS RELATED TO HIGHLY EMETOGENIC CHEMOTHERAPY - DOSE, SCHEDULE, ANDROUTE OF ADMINISTRATION
Authors: GANDARA DR ROILA F WARR D EDELMAN MJ PEREZ EA GRALLA RJ
Citation: Dr. Gandara et al., CONSENSUS PROPOSAL FOR 5HT(3) ANTAGONISTS IN THE PREVENTION OF ACUTE EMESIS RELATED TO HIGHLY EMETOGENIC CHEMOTHERAPY - DOSE, SCHEDULE, ANDROUTE OF ADMINISTRATION, Supportive care in cancer, 6(3), 1998, pp. 237-243
RANDOMIZED TRIAL OF INTENSIVE CYCLOPHOSPHAMIDE, EPIRUBICIN, AND FLUOROURACIL CHEMOTHERAPY COMPARED WITH CYCLOPHOSPHAMIDE, METHOTREXATE, ANDFLUOROURACIL IN PREMENOPAUSAL WOMEN WITH NODE-POSITIVE BREAST-CANCER
Authors: LEVINE MN BRAMWELL VH PRITCHARD KI NORRIS BD SHEPHERD LE ABUZAHRA H FINDLAY B WARR D BOWMAN D MYLES J ARNOLD A VANDENBERG T MACKENZIE R ROBERT J OTTAWAY J BURNELL M WILLIAMS CK TU DS
Citation: Mn. Levine et al., RANDOMIZED TRIAL OF INTENSIVE CYCLOPHOSPHAMIDE, EPIRUBICIN, AND FLUOROURACIL CHEMOTHERAPY COMPARED WITH CYCLOPHOSPHAMIDE, METHOTREXATE, ANDFLUOROURACIL IN PREMENOPAUSAL WOMEN WITH NODE-POSITIVE BREAST-CANCER, Journal of clinical oncology, 16(8), 1998, pp. 2651-2658
USE OF DEXAMETHASONE AND GRANISETRON IN THE CONTROL OF DELAYED EMESISFOR PATIENTS WHO RECEIVE HIGHLY EMETOGENIC CHEMOTHERAPY
Authors: LATREILLE J PATER J JOHNSTON D LABERGE F STEWART D RUSTHOVEN J HOSKINS P FINDLAY B MCMURTRIE E YELLE L WILLIAMS C WALDE D ERNST S DHALIWAL H WARR D SHEPHERD F MEE D NISHIMURA L OSOBA D ZEE B
Citation: J. Latreille et al., USE OF DEXAMETHASONE AND GRANISETRON IN THE CONTROL OF DELAYED EMESISFOR PATIENTS WHO RECEIVE HIGHLY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 16(3), 1998, pp. 1174-1178
WHEN YOU CARRY CONDOMS ALL THE BOYS THINK YOU WANT IT - NEGOTIATING COMPETING DISCOURSES ABOUT SAFE SEX
Authors: HILLIER L HARRISON L WARR D
Citation: L. Hillier et al., WHEN YOU CARRY CONDOMS ALL THE BOYS THINK YOU WANT IT - NEGOTIATING COMPETING DISCOURSES ABOUT SAFE SEX, Journal of adolescence, 21(1), 1998, pp. 15-29
EFFECT OF POSTCHEMOTHERAPY NAUSEA AND VOMITING ON HEALTH-RELATED QUALITY-OF-LIFE
Authors: OSOBA D ZEE B WARR D LATREILLE J KAIZER L PATER J
Citation: D. Osoba et al., EFFECT OF POSTCHEMOTHERAPY NAUSEA AND VOMITING ON HEALTH-RELATED QUALITY-OF-LIFE, Supportive care in cancer, 5(4), 1997, pp. 307-313
STANDARD TREATMENT OF CHEMOTHERAPY-INDUCED EMESIS
Authors: WARR D
Citation: D. Warr, STANDARD TREATMENT OF CHEMOTHERAPY-INDUCED EMESIS, Supportive care in cancer, 5(1), 1997, pp. 12-16
RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL CHEMOTHERAPY ADDED TO TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH NODE-POSITIVE ESTROGEN AND OR PROGESTERONE RECEPTOR-POSITIVE BREAST-CANCER - A REPORT OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/
Authors: PRITCHARD KI PATERSON AHG FINE S PAUL NA ZEE B SHEPHERD LE ABUZAHRA H RAGAZ J KNOWLING M LEVINE MN VERMA S PERRAULT D WALDE PLD BRAMWELL VHC POLJICAK M BOYD N WARR D NORRIS BD BOWMAN D ARMITAGE GR WEIZEL H BUCKMAN RA
Citation: Ki. Pritchard et al., RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL CHEMOTHERAPY ADDED TO TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH NODE-POSITIVE ESTROGEN AND OR PROGESTERONE RECEPTOR-POSITIVE BREAST-CANCER - A REPORT OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/, Journal of clinical oncology, 15(6), 1997, pp. 2302-2311
DETERMINANTS OF POSTCHEMOTHERAPY NAUSEA AND VOMITING IN PATIENTS WITHCANCER
Authors: OSOBA D ZEE B PATER J WARR D LATREILLE J KAIZER L
Citation: D. Osoba et al., DETERMINANTS OF POSTCHEMOTHERAPY NAUSEA AND VOMITING IN PATIENTS WITHCANCER, Journal of clinical oncology, 15(1), 1997, pp. 116-123
QUALITY-OF-LIFE STUDIES IN CHEMOTHERAPY-INDUCED EMESIS
Authors: OSOBA D ZEE B WARR D KAIZER L LATREILLE J PATER J
Citation: D. Osoba et al., QUALITY-OF-LIFE STUDIES IN CHEMOTHERAPY-INDUCED EMESIS, Oncology, 53, 1996, pp. 92-95
DEXAMETHASONE IMPROVES THE EFFICACY OF GRANISETRON IN THE FIRST 24 H FOLLOWING HIGH-DOSE CISPLATIN CHEMOTHERAPY
Authors: LATREILLE J STEWART D LABERGE F HOSKINS P RUSTHOVEN J MCMURTRIE E WARR D YELLE L WALDE D SHEPHERD F DHALIWAL H FINDLAY B MEE D PATER J ZEE B JOHNSTON D
Citation: J. Latreille et al., DEXAMETHASONE IMPROVES THE EFFICACY OF GRANISETRON IN THE FIRST 24 H FOLLOWING HIGH-DOSE CISPLATIN CHEMOTHERAPY, Supportive care in cancer, 3(5), 1995, pp. 307-312
A RANDOMIZED TRIAL OF THE EFFECTS OF PHARMACIST INTERVENTION ON THE COST OF ANTIEMETIC THERAPY WITH ONDANSETRON
Authors: DRANITSARIS G WARR D PUODZIUNAS A
Citation: G. Dranitsaris et al., A RANDOMIZED TRIAL OF THE EFFECTS OF PHARMACIST INTERVENTION ON THE COST OF ANTIEMETIC THERAPY WITH ONDANSETRON, Supportive care in cancer, 3(3), 1995, pp. 183-189
ANTIEMETIC PROPERTIES OF GRANISETRON
Authors: PATER JL WARR D
Citation: Jl. Pater et D. Warr, ANTIEMETIC PROPERTIES OF GRANISETRON, The New England journal of medicine, 332(24), 1995, pp. 1653-1653
RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER
Authors: HOLMES CE RUCKDESCHEL JC JOHNSTON M THOMAS PA DESLAURIERS J GROVER FL HILL LD FELD R GINSBERG RJ MOUNTAIN CF DZUIBAN S KIELY M MCKNEALLY MF MOORES DWO RAMNES C WAGNER H BUNN P CHU H DIENHART D HAZUKA M KINZIE J SORENSEN J VANCE V BRAUN T HOPEMAN A KANE M RUSS P WHITMAN GJR FALL SM HANSEN DP HENDERSON RH MONCRIEF CL PAULING F SIMS J TELL D WISELYCARR S ABERNATHY CM CLARK DA MCCROSKEY B MOORE G MOORE F MYERS A WHITE M BROOKS RJ BULL M JOHNSON FB NEIMYR M PAQUETTE FR SACCOMANNO G LAD T HERMANSEN K LIEBNER E MCGUIRE WP FRY W STEMPELFELD B ALEXANDER JC BECK J GARCES RM IMPERATO JP KAHANDEKAR J KNOP R LOCKER G MERKEL DE PANELLA JS ROCHESTER D VICTOR TA JOHNSON C JOOB AW ROBINSON P ROSEN S SHIELDS T DOOLEY S TIO FO HOLLAND C TREASURE RL GOTTFRIED B BEDDINGFIELD G BOWER J CHENG D DALY MB LADD WA LEACH C MURPHY K QUINTON R SMITH VC YOUNG ME BLANTON M BRIGGS R GRISHKIN BA HELSEL R JACKSON D JACKSON ME YOUNG R ZALOZNIK A BLOCK K DAIL DH DREIS D GUYTON SW HAFERMANN M HAMMAR SP JOLLY PC MORGAN E SPRINGMEYER S TAYLOR EW WEIDEN PW KNUDSEN N LIVINGSTON RB RUSCH VW GRAFTON C LERICHE J MURRAY N PAGE R GOODMAN GE AYE RW EVANS KG MILLER RR NELEMS B HIGANO C BERGSAGEL D BROWN TC CURTIS J PAYNE D PRINGLE JF QUIRT I STEWARD L WARR D YEOH L BURKES R COOTER N GOLDBERG M MULLEN B SCHMOCKER B HARRIS F ILVES R SINCLAIR JM SPRATT E BAKER M CHAMBERLAIN DW COOPER JD DESANTIS D EVANS WK PATTERSON GA PEARSON FG RITCHIE AC SHEPHERD FA TAYLOR D TODD TRJ WEBSTER J WINTON TL KIRBY TJ LIPA M FRENCH S SUTTON D WARNER E WATERS PF JONES D HOLMES EC SELCH RA SHIPLACOFF J GANZ P SILVERMAN B HASKELL C SADEGHI A WILLIAMS A WOLLMAN J BLOCH JH CORDER MP HERMES K LUKEMAN JM MURPHY A PIANTADOSI S GOODMAN S RUBINSTEIN LV GAIL MH BOSSENGA M LAKE WH LONG S
Citation: Ce. Holmes et al., RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER, The Annals of thoracic surgery, 60(3), 1995, pp. 615-622
PSYCHOMETRIC PROPERTIES AND RESPONSIVENESS OF THE EORTC QUALITY-OF-LIFE QUESTIONNAIRE (QLQ-C30) IN PATIENTS WITH BREAST, OVARIAN AND LUNG-CANCER
Authors: OSOBA D ZEE B PATER J WARR D KAIZER L LATREILLE J
Citation: D. Osoba et al., PSYCHOMETRIC PROPERTIES AND RESPONSIVENESS OF THE EORTC QUALITY-OF-LIFE QUESTIONNAIRE (QLQ-C30) IN PATIENTS WITH BREAST, OVARIAN AND LUNG-CANCER, Quality of life research, 3(5), 1994, pp. 353-364
PSYCHOMETRIC AND DISCRIMINATORY PROPERTIES OF THE EORTC QUALITY-OF-LIFE QUESTIONNAIRE (QLQ-C30) IN PATIENTS WITH EITHER LUNG, BREAST OR OVARIAN-CANCER
Authors: OSOBA D ZEE B WARR D KAISER L LATREILLE J
Citation: D. Osoba et al., PSYCHOMETRIC AND DISCRIMINATORY PROPERTIES OF THE EORTC QUALITY-OF-LIFE QUESTIONNAIRE (QLQ-C30) IN PATIENTS WITH EITHER LUNG, BREAST OR OVARIAN-CANCER, Quality of life research, 3(1), 1994, pp. 54-54
INCONSISTENCY OF PROGNOSTIC FACTORS FOR POSTCHEMOTHERAPY NAUSEA AND VOMITING
Authors: PATER J SLAMET L ZEE B OSOBA D WARR D RUSTHOVEN J
Citation: J. Pater et al., INCONSISTENCY OF PROGNOSTIC FACTORS FOR POSTCHEMOTHERAPY NAUSEA AND VOMITING, Supportive care in cancer, 2(3), 1994, pp. 161-166
EFFECT OF SCHEDULE AND MAINTENANCE ON THE ANTIEMETIC EFFICACY OF ONDANSETRON COMBINED WITH DEXAMETHASONE IN ACUTE AND DELAYED NAUSEA AND EMESIS IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY - A PHASE-III TRIAL BY THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALSGROUP
Authors: KAIZER L WARR D HOSKINS P LATREILLE J LOFTERS W YAU J PALMER M ZEE B LEVY M PATER J
Citation: L. Kaizer et al., EFFECT OF SCHEDULE AND MAINTENANCE ON THE ANTIEMETIC EFFICACY OF ONDANSETRON COMBINED WITH DEXAMETHASONE IN ACUTE AND DELAYED NAUSEA AND EMESIS IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY - A PHASE-III TRIAL BY THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALSGROUP, Journal of clinical oncology, 12(5), 1994, pp. 1050-1057
PHASE-II TRIAL OF 5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OFADVANCED BREAST-CANCER
Authors: FINE S ERLICHMAN C KAIZER L WARR D GADALLA T
Citation: S. Fine et al., PHASE-II TRIAL OF 5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OFADVANCED BREAST-CANCER, Breast cancer research and treatment, 30(2), 1994, pp. 205-209
DOUBLE-BLIND RANDOMIZED TRIAL OF VERY-LOW-DOSE WARFARIN FOR PREVENTION OF THROMBOEMBOLISM IN STAGE-IV BREAST-CANCER
Authors: LEVINE M HIRSH J GENT M ARNOLD A WARR D FALANGA A SAMOSH M BRAMWELL V PRITCHARD KI STEWART D GOODWIN P
Citation: M. Levine et al., DOUBLE-BLIND RANDOMIZED TRIAL OF VERY-LOW-DOSE WARFARIN FOR PREVENTION OF THROMBOEMBOLISM IN STAGE-IV BREAST-CANCER, Lancet, 343(8902), 1994, pp. 886-889
OUTCOME AND PROGNOSTIC FACTORS IN SOFT-TISSUE SARCOMA IN THE ADULT
Authors: LEVAY J OSULLIVAN B CATTON C BELL R FORNASIER V CUMMINGS B HAO Y WARR D QUIRT I
Citation: J. Levay et al., OUTCOME AND PROGNOSTIC FACTORS IN SOFT-TISSUE SARCOMA IN THE ADULT, International journal of radiation oncology, biology, physics, 27(5), 1993, pp. 1091-1099
A DOUBLE-BLIND RANDOMIZED TRIAL OF MINI-DOSE WARFARIN FOR THE PREVENTION OF THROMBOEMBOLISM (TE) IN PATIENTS WITH STAGE-IV BREAST-CANCER
Authors: LEVINE MN HIRSH J GENT M ARNOLD A WARR D FALANGA A SAMOSH M BRAMWELL V PRITCHARD K STEWART D GOODWIN P DICKSON L
Citation: Mn. Levine et al., A DOUBLE-BLIND RANDOMIZED TRIAL OF MINI-DOSE WARFARIN FOR THE PREVENTION OF THROMBOEMBOLISM (TE) IN PATIENTS WITH STAGE-IV BREAST-CANCER, Thrombosis and haemostasis, 69(6), 1993, pp. 981-981
Risultati: 1-22 |